Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial

Zhang, Le; Wang, Weixue; Ge, Shaohua; Li, Hongli; Bai, Ming; Duan, Jingjing; Yang, Yuchong; Ning, Tao; Liu, Rui; Wang, Xia; Ji, Zhi; Wang, Feixue; Zhang, Haiyang; Ba, Yi; Deng, Ting

doi:10.1186/s12885-023-10661-4

BMC Cancer

Article metrics
Last updated: Sat, 20 Apr 2024 8:12:46 Z

Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial

Access & Citations

1470

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com